These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 34724875)
41. Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens. Chellapandian D; Das R; Zelley K; Wiener SJ; Zhao H; Teachey DT; Nichols KE; Br J Haematol; 2013 Aug; 162(3):376-82. PubMed ID: 23692048 [TBL] [Abstract][Full Text] [Related]
42. [Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis during pregnancy]. Ikeda M; Oba R; Yoshiki Y; Shingaki S; Takei T; Miyazaki K; Abe Y; Tsukada N; Ishida T; Suzuki K Rinsho Ketsueki; 2017; 58(3):216-221. PubMed ID: 28381688 [TBL] [Abstract][Full Text] [Related]
43. [Clinical Characteristics and Prognostic Analysis of 59 Adult Patients with Epstein-Barr Virus-Associated Hemophagocytic Syndrome]. Zhou YL; Li F; Zhang RY; Chen ZW; Zhong N; Tang WP Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):657-662. PubMed ID: 32319412 [TBL] [Abstract][Full Text] [Related]
44. Treatment outcomes and prognostic factors for non- malignancy associated secondary hemophagocytic lymphohistiocytosis in children. Pan H; Wang G; Guan E; Song L; Song A; Liu X; Yi Z; Sun LR BMC Pediatr; 2020 Jun; 20(1):288. PubMed ID: 32517812 [TBL] [Abstract][Full Text] [Related]
45. Malignancy-associated haemophagocytic lymphohistiocytosis in children and adolescents. Lehmberg K; Sprekels B; Nichols KE; Woessmann W; Müller I; Suttorp M; Bernig T; Beutel K; Bode SF; Kentouche K; Kolb R; Längler A; Minkov M; Schilling FH; Schmid I; Vieth S; Ehl S; Zur Stadt U; Janka GE Br J Haematol; 2015 Aug; 170(4):539-49. PubMed ID: 25940575 [TBL] [Abstract][Full Text] [Related]
46. Clinical presentation and outcome of pediatric patients with hemophagocytic lymphohistiocytosis in China: A retrospective multicenter study. Xu XJ; Wang HS; Ju XL; Xiao PF; Xiao Y; Xue HM; Shi HY; Gao YJ; Jia GC; Li XR; Zhao WH; Wang NL; Tang YM; Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27781387 [TBL] [Abstract][Full Text] [Related]
47. Spectrum and trigger identification of hemophagocytic lymphohistiocytosis in adults: A single-center analysis of 555 cases. Miao Y; Zhang J; Chen Q; Xing L; Qiu T; Zhu H; Wang L; Fan L; Xu W; Li J Front Immunol; 2022; 13():970183. PubMed ID: 36032133 [TBL] [Abstract][Full Text] [Related]
48. Haemophagocytic lymphohistiocytosis and Epstein-Barr virus: a complex relationship with diverse origins, expression and outcomes. El-Mallawany NK; Curry CV; Allen CE Br J Haematol; 2022 Jan; 196(1):31-44. PubMed ID: 34169507 [TBL] [Abstract][Full Text] [Related]
50. [Clinical features and outcome analysis of 83 childhood Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with HLH-2004 protocol]. Xiao L; Xian Y; Dai BT; Su YC; Xiao JW; Zheng QC; Zhao XD; Yu J Zhonghua Xue Ye Xue Za Zhi; 2011 Oct; 32(10):668-72. PubMed ID: 22339824 [TBL] [Abstract][Full Text] [Related]
51. [Report of a case with secondary acute promyelocytic leukemia after therapy for hemophagocytic lymphohistiocytosis and review of literature]. Su Y; Zhou X; Zhang L; Zhang R Zhonghua Er Ke Za Zhi; 2013 Dec; 51(12):938-42. PubMed ID: 24495767 [TBL] [Abstract][Full Text] [Related]
52. A case of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with severe cardiac complications. Kawamura Y; Miura H; Matsumoto Y; Uchida H; Kudo K; Hata T; Ito Y; Kimura H; Yoshikawa T BMC Pediatr; 2016 Oct; 16(1):172. PubMed ID: 27793118 [TBL] [Abstract][Full Text] [Related]
54. Wei A; Lu X; Ma H; Lian H; Yang X; Zhang L; Wang D; Chen S; Zhang Q; Li Z; Zhang R; Yang J; Wang T Contrast Media Mol Imaging; 2022; 2022():4849081. PubMed ID: 35510179 [TBL] [Abstract][Full Text] [Related]
55. Spontaneous Recovery of Hemophagocytic Lymphohistiocytosis Due to Primary Epstein-Barr Virus Infection in an Adult Patient. Matsuo Y; Iwanami K; Hiraoka E; Oda R Am J Case Rep; 2021 Oct; 22():e933272. PubMed ID: 34657119 [TBL] [Abstract][Full Text] [Related]
56. Prognostic Value of Blood-Based Inflammatory Biomarkers in Secondary Hemophagocytic Lymphohistiocytosis. Huang J; Yin G; Duan L; Tian T; Xu J; Wang J; Gao X; Cheng W; Liu L; Qiu H J Clin Immunol; 2020 Jul; 40(5):718-728. PubMed ID: 32495220 [TBL] [Abstract][Full Text] [Related]
57. Assessment of immunochemotherapy and stem cell transplantation on EBV-associated hemophagocytic lymphohistiocytosis in children: a systematic review and meta analysis. Qin Q; Xie Z; Shen Y; Yang S; Liu C; Huang Z; Xu J; Al J; Shen K Eur Rev Med Pharmacol Sci; 2012 May; 16(5):672-8. PubMed ID: 22774410 [TBL] [Abstract][Full Text] [Related]
58. High concentration of miR-133 is a useful marker for the diagnosis of lymphoma- associated hemophagocytic syndrome. Li W; Zhong Y; Shuang Y; Huang H; Huang Y; Yu L; Huang X Cancer Biomark; 2017 Aug; 20(2):159-164. PubMed ID: 28869447 [TBL] [Abstract][Full Text] [Related]
59. Ruxolitinib is an alternative to etoposide for patient with hemophagocytic lymphohistiocytosis complicated by acute renal injury: A case report. Yan WL; Yang SL; Zhao FY; Xu XJ J Oncol Pharm Pract; 2022 Jan; 28(1):222-227. PubMed ID: 34074166 [TBL] [Abstract][Full Text] [Related]
60. Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in a small child: A case report. Mărginean MO; Molnar E; Chinceşan MI Medicine (Baltimore); 2020 Jan; 99(3):e18759. PubMed ID: 32011461 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]